Product category:
Nucleic acid sequencing and synthesis
News Release from: Bio-Rad Laboratories | Subject: BioPlex 2200 EBV IgG and IgM kits
Edited by the Laboratorytalk Editorial
Team on 03 April 2007
Epstein Barr virus kits for use on
BioPlex 2200
Bio-Rad Laboratories has launched two Epstein Barr Virus (EBV) kits for use on its BioPlex 2200 system, a diagnostic platform that employs multiplexing technology to s for multiple disease markers
Bio-Rad's BioPlex 2200 system is a diagnostic platform that employs multiplexing technology to analyse for multiple disease markers from a single patient sample "We are extremely pleased to offer our customers two new kits for EBV, including the only heterophile IgM assay available on an automated platform," said John Goetz, vice president of Bio-Rad's clinical diagnostics group
This article was originally published on Laboratorytalk on 19 Feb 2002 at 8.00am (UK)
Related stories
Fully automated BSE testing system
New tests and automated platform promise to increase efficiency, produce faster results, expand mass screening capabilities, and reduce costs
"The release of the BioPlex 2200 EBV IgG and IgM kits is another example of Bio-Rad's commitment to providing valuable tools that provide laboratories ways to improve testing methods, maximize efficiencies, and lower costs".
Each of the two kits provides for multiple results from a single patient sample.
The IgG kit includes assays for EBV VCA, EBV NA-1, and EBV EA-D, and the IgM kit includes assays for EBV VCA and heterophile antibodies.
By delivering results for five of the most clinically relevant antibodies, the BioPlex 2200 system enables laboratories to rapidly determine patient serological status on a fully automated and fully integrated random access platform. Request a free brochure from Bio-Rad Laboratories ...
• Bio-Rad Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
